| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245894 Reshaped human antibody to human interleukin-8 |
| 06/12/2001 | US6245889 BMP-4 products |
| 06/12/2001 | US6245888 Proteins involved in the regulation of cell—cell adhesion and uses thereof |
| 06/12/2001 | US6245887 An isolated enzyme; for producing large quantities of c-terminal .alpha.-amidating enzyne |
| 06/12/2001 | US6245886 Peptides and peptidomimetics with structural similarity to human P53 that activate P53 function |
| 06/12/2001 | US6245885 Bax-mediated apoptosis modulating reagents and methods |
| 06/12/2001 | US6245748 Inhibition of an FGF-binding protein using ribozymes |
| 06/12/2001 | US6245747 Targeted site specific antisense oligodeoxynucleotide delivery method |
| 06/12/2001 | US6245741 Protein Z-dependent protease inhibitor |
| 06/12/2001 | US6245739 polypeptides and polypeptide analogues |
| 06/12/2001 | US6245737 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
| 06/12/2001 | US6245567 Activating egg extracts and method of preparation |
| 06/12/2001 | US6245566 Human embryonic germ cell line and methods of use |
| 06/12/2001 | US6245565 Recombinase Mediated DNA modifications |
| 06/12/2001 | US6245562 Determining chromosomal breakpoint gene other than the immunoglobulin gene which is located in chromosome 14; complex between probe and the mrna; multiple myeloma |
| 06/12/2001 | US6245560 Vector with multiple target response elements affecting gene expression |
| 06/12/2001 | US6245550 Nucleotide sequence from gene homologous to erythropoetin and growth hormone; diagnosis; therapy of blood disorders, developmental/growth defects, and obesity; anti-inflammatory, antidiabetic, anticarcinogenic agents |
| 06/12/2001 | US6245547 Carboxymethyl cellulose from thermotoga maritima |
| 06/12/2001 | US6245546 Animal feed additives |
| 06/12/2001 | US6245545 Culturing a cell transformed with the vector comprising the isolated dna encoding the endonuclease of staphloccus warneri; used to cleave dna molecules into fragments for molecular cloning and gene characterization |
| 06/12/2001 | US6245544 An isolated polypeptide having a specific amino acid sequence; antiproliferative, anticarcinogenic, antitumor, antiarthritic, antiinflammatory agents; metastatsis; psoriasis; vision defects |
| 06/12/2001 | US6245541 Isolated spinach ribulose-1,5-bisphosphate carboxylase/oxgenase large subunit ε n-methyltransferase and method of inactivating ribulose-1,5-bishosphatase ε n-methyltransferase activity |
| 06/12/2001 | US6245540 Human choline acetyltransferase |
| 06/12/2001 | US6245533 Nucleic acid-free thermostable enzymes and methods of production thereof |
| 06/12/2001 | US6245531 Polynucleotide encoding insect ecdysone receptor |
| 06/12/2001 | US6245530 Receptor ligand |
| 06/12/2001 | US6245528 Latent baculovirus expression system |
| 06/12/2001 | US6245527 Nucleotide sequence which encodes preferential platelet receptors; for the diagnosis and treatment of atherosclerosis, cardiovascular disorders and tumor metastasis; antitumor agents |
| 06/12/2001 | US6245526 Mammalian nucleotide sequences which code polypeptides for the classification, diagnosis, treatment, and prevention of cell proliferative and lipid defects |
| 06/12/2001 | US6245524 Phenylacetyl-CoA ligase from penicillium chrysogenum |
| 06/12/2001 | US6245523 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/12/2001 | US6245519 Protection probes |
| 06/12/2001 | US6245516 Nucleotide sequences for the detction of microorganisms in a sample |
| 06/12/2001 | US6245515 Double stranded dna fragment which has a p53 specific binding site and is covalently attached to insoluble polymer support |
| 06/12/2001 | US6245514 Fluorescent donor-acceptor pair with low spectral overlap |
| 06/12/2001 | US6245513 Detecting presence or absence of substance in sample; incubate sample with nucleotide sequences, amplify bound complex, incubate complex with label, detect bound label |
| 06/12/2001 | US6245512 Promoter for VEGF receptor |
| 06/12/2001 | US6245510 Isolating preferential plant nucleotide sequences; incubate plant nucleotide sequences with probe, isolate hybridization products |
| 06/12/2001 | US6245509 Generating oligonucleotide probe for detecting infections; determine nucleotide sequence of target and non target sample cells, detect preferential nucleotide sequences, synthesize and recover oligonucleotide probe |
| 06/12/2001 | US6245508 Hybridizing dna of first length to capture probes at site, hybridizing dna of second length to capture probes at another site, observing fluorescent signals as potential is reversed, detecting sites which dehybridize at a potential |
| 06/12/2001 | US6245505 Selective ligation and amplification method |
| 06/12/2001 | US6245504 Transducing phages of Actinomycetales |
| 06/12/2001 | US6245503 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 06/12/2001 | US6245427 Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles |
| 06/12/2001 | US6245338 OMP26 antigen from Haemophilus influenzae |
| 06/12/2001 | US6245337 Haemophilus adherence and penetration proteins |
| 06/12/2001 | US6245335 Choline binding proteins for anti-pneumococcal vaccines |
| 06/12/2001 | US6245333 Isolated protein processed to peptides which form complexes with HLA molecules |
| 06/12/2001 | US6245330 Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF) |
| 06/12/2001 | US6245329 Method of inducing calcium flux in cells using mammalian thymokine protein |
| 06/12/2001 | CA2222769C Primers for the detection of hiv-1 |
| 06/12/2001 | CA2173595C Dna encoding prostaglandin receptor ip |
| 06/12/2001 | CA2159374C Holder assembly for reaction tubes |
| 06/12/2001 | CA2126250C Method, reagents and kits for the detection of neisseria gonorrhoeae |
| 06/12/2001 | CA2117477C Multivalent single chain antibodies |
| 06/12/2001 | CA2113478C Functionalized carrier materials for the simultaneous synthesis and direct labelling of oligonucleotides as primers for template-dependent enzymatic nucleic acid syntheses |
| 06/12/2001 | CA2092717C Expression of g protein coupled receptors in yeast |
| 06/12/2001 | CA2070831C Dna, constructs, cells and plants derived therefrom |
| 06/12/2001 | CA2060505C Method for recovering recombinant proteins |
| 06/12/2001 | CA2050058C Recombinant mite allergen |
| 06/12/2001 | CA2043953C Method for the isolation and expression of a gene which codes for streptokinase, nucleotide sequence obtained, recombinant dna and transformed microorganisms |
| 06/12/2001 | CA1341251C Pox virus vectors |
| 06/12/2001 | CA1341249C Expression and purification of an htlv-iii gag/env gene protein |
| 06/10/2001 | CA2326730A1 Novel nucleotide sequences coding for the genes sdha, sdhb and sdhc |
| 06/09/2001 | CA2325766A1 Novel nucleotide sequences coding for the zwa2 gene |
| 06/09/2001 | CA2325593A1 Process for the fermentative preparation of l-amino acids using coryneform bacteria |
| 06/08/2001 | CA2325253A1 High-throughput screening of compounds using electrospray ionization mass spectroscopy |
| 06/07/2001 | WO2001040969A1 Exson-intron junction determining device, genetic region determining device, and determining method for them |
| 06/07/2001 | WO2001040803A1 Direct screening method |
| 06/07/2001 | WO2001040798A2 Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
| 06/07/2001 | WO2001040786A1 Electric-field-assisted fluidic assembly of inorganic and organic materials, molecules and like small things including living cells |
| 06/07/2001 | WO2001040521A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | WO2001040520A1 Methods for determining single nucleotide variations and genotyping |
| 06/07/2001 | WO2001040519A2 Methods for identifying modulators for balance related disorders |
| 06/07/2001 | WO2001040518A1 Targeted methods of drug screening using co-culture methods |
| 06/07/2001 | WO2001040517A2 Evaluating and predicting clinical outcomes by gene expression analysis |
| 06/07/2001 | WO2001040516A2 Generation of single-strand circular dna from linear self-annealing segments |
| 06/07/2001 | WO2001040512A2 Resistance gene |
| 06/07/2001 | WO2001040506A1 Method of measuring deacetylase activity and method of screening inhibitor or promoter of these enzymes |
| 06/07/2001 | WO2001040499A2 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 06/07/2001 | WO2001040497A2 Method for obtaining nucleic acids from an environment sample |
| 06/07/2001 | WO2001040494A1 Drug inducible system and use thereof |
| 06/07/2001 | WO2001040492A2 Inducible site-specific recombination for the activation and removal of transgenes in transgenic plants |
| 06/07/2001 | WO2001040491A2 Udp-glucose:aglycon-glucosyltransferase |
| 06/07/2001 | WO2001040490A2 Eukaryotic initiation factor 4e inhibitors and their use as herbicides |
| 06/07/2001 | WO2001040489A1 Methods for producing a polypeptide using a consensus translational initiator sequence |
| 06/07/2001 | WO2001040488A1 Increased transgene expression in retroviral vectors having scaffold attachment region |
| 06/07/2001 | WO2001040487A1 Novel polypeptide---human ii aminoacyl-trna synthetase9 and polynucleotide encoding it |
| 06/07/2001 | WO2001040486A1 Novel polypeptide---human atp-dependent serine protease 48 and polynucleotide encoding it |
| 06/07/2001 | WO2001040485A1 Novel polypeptide-ef-chiral calcium-binding protein 62 containing atp/gtp binding structural domain and polynucleotide encoding it |
| 06/07/2001 | WO2001040484A2 A novel polypeptide, a human atp-dependent serine protease 64 and the polynucleotide encoding the polypeptide |
| 06/07/2001 | WO2001040483A1 Novel polypeptide---human lipoprotein 105 containing cytochrome c structural domain and polynucleotide encoding it |
| 06/07/2001 | WO2001040482A1 Novel polypeptide---eukaryotic acetyltransferase 11 and polynucleotide encoding it |
| 06/07/2001 | WO2001040481A1 Novel polypeptide -- human neuro:transmitter co-transporter membrane protein 13 and polynucleotide encoding it |
| 06/07/2001 | WO2001040480A1 Novel polypeptide - human endopolypeptidase 6 and polynucleotide encoding it |
| 06/07/2001 | WO2001040479A1 Novel polypeptide, ef-chiral calcium-binding protein 96 containing atp/gtp binding structural domain and polynucleotide encoding it |
| 06/07/2001 | WO2001040478A2 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 06/07/2001 | WO2001040477A1 Transposase and method of gene modification |
| 06/07/2001 | WO2001040476A2 Bacillus thuringiensis toxin active against formicidae (ant) |